Muscle Relaxant Drugs Market is expected to generate a revenue of USD 6.59 Billion by 2031, Globally, at 5.4% CAGR: Verified Market Research®

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, " Muscle Relaxant ...
Becker's Hospital Review

FDA approves Lanett’s muscle relaxant drug: 3 things to know

Here are three things to know. 1. The drug is a muscle relaxant intended to treat patients with acute, painful musculoskeletal conditions. 2. Metaxalone tablets are a generic version of King ...
Healio

Common muscle relaxants associated with increased COPD exacerbation risk

Please provide your email address to receive an email when new articles are posted on . Patients using cyclobenzaprine or methocarbamol had increased relative risk for COPD exacerbations, researchers ...
pix11

Nationwide drug recall for popular muscle relaxer in effect: FDA

NEW YORK (PIX11) – A popular muscle relaxer made in New Jersey is being recalled due to a label swap, according to the FDA. The product was distributed nationwide to distributors, the recall stated.
Healio

FDA grants fast track designation to cyclobenzaprine tablets for fibromyalgia

Please provide your email address to receive an email when new articles are posted on . Tonmya significantly reduced daily pain vs. placebo in a phase 3 trial in fibromyalgia. Fast track designation ...
AOL

Recall: The label says muscle relaxer, but arthritis drugs are in the bottle

Unichem Pharmaceuticals has recalled one lot of a muscle relaxer because the pills in the bottle might not be the muscle relaxer on the label. The East Brunswick, New Jersey, company’s FDA-posted ...
Becker's Hospital Review

Drugmaker recalls muscle relaxant over labeling error

Unichem pharmaceuticals issued a nationwide recall of one lot of cyclobenzaprine hydrochloride tablets after finding that bottles labeled as the muscle relaxant actually contained meloxicam, a ...